Safety assessment of biologics in genO-BRGSF HIS: a highly predictive and translational mouse model

Content

‍

▶️ genO-BRGSF-HIS mouse model develops both human lymphoid and myeloid compartments

‍

▶️ TME in genO-BRGSF-HIS mice is shaped by tumor type and tumor burden

‍

▶️ genO-BRGSF-HIS is suitable to investigate efficacy and Immune-Related Adverse Events of therapeutics

Speaker

‍

Claire Da Silva Santos, PhD, is a Key Account Manager at genOway, specializing in preclinical models for immuno-oncology and inflammation. She brings extensive expertise in managing portfolios that support translational research for drug development.

‍